# SHARE: Simple HAART With Abacavir, Reyataz, and Epivir

> **NCT00426296** · PHASE4 · UNKNOWN · sponsor: **Clinical Alliance for Research & Education - Infectious Diseases, LLC.**

## Conditions studied

- HIV Infections
- Lipodystrophy

## Interventions

- **DRUG:** atazanavir (Reyataz)
- **DRUG:** ritonavir (Norvir)

## Key facts

- **NCT ID:** NCT00426296
- **Lead sponsor:** Clinical Alliance for Research & Education - Infectious Diseases, LLC.
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2006-08
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2007-11-01

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00426296

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00426296, "SHARE: Simple HAART With Abacavir, Reyataz, and Epivir". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00426296. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*